BAYER AG
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Public
- Established
- 1863-08-01
- Employees
- 99.7K
- Market Cap
- $30.1B
- Website
- http://www.bayer.com
Study to Test the Usability of a New Injector to Administer Contrast Media Into Humans for Diagnostic Purposes
Not Applicable
Completed
- Conditions
- Computed Tomography
- Interventions
- Device: Stellant MP injectorDevice: Centargo injector (BPI 1000045)
- First Posted Date
- 2019-03-14
- Last Posted Date
- 2021-03-03
- Lead Sponsor
- Bayer
- Target Recruit Count
- 425
- Registration Number
- NCT03875469
- Locations
- 🇳🇱
Maastricht University Medical Center, Maastricht, Limburg, Netherlands
🇦🇺Medscan, Merrylands, New South Wales, Australia
Study Performed at Various Medical Centers to Learn More About Survival and Expected Course of Pulmonary Arterial Hypertension, a Type of High Blood Pressure in the Lungs Related to the Narrowing of the Small Blood Vessels in the Lungs
- First Posted Date
- 2019-03-05
- Last Posted Date
- 2021-05-04
- Lead Sponsor
- Bayer
- Target Recruit Count
- 104
- Registration Number
- NCT03863990
- Locations
- 🇦🇷
Many facilities, Multiple Locations, Argentina
A Study to Gain Information How Well Dexpanthenol Dermal Spray Helps the Skin to Recover After Laser Hair Removal in the Groin and Intimate Area
Phase 4
Completed
- Conditions
- Skin Recovery
- Interventions
- Drug: BAY207543 (Bepanthol, Bepantol® Derma Spray)Other: Semisolid vaseline
- First Posted Date
- 2019-02-25
- Last Posted Date
- 2020-03-11
- Lead Sponsor
- Bayer
- Target Recruit Count
- 35
- Registration Number
- NCT03853525
- Locations
- 🇧🇷
Medcin Instituto da Pele, Sao Paulo, Brazil
A Study to Gain Information How Well Dexpanthenol Derma Cream Helps the Face Skin to Recover After Cosmetic Lasering
Not Applicable
Completed
- Conditions
- ErythemaSkin Recovery
- Interventions
- Drug: BAY207543 (Bepanthol)Other: Semisolid vaseline
- First Posted Date
- 2019-02-25
- Last Posted Date
- 2020-04-20
- Lead Sponsor
- Bayer
- Target Recruit Count
- 33
- Registration Number
- NCT03852563
- Locations
- 🇧🇷
Medcin Instituto da Pele, Sao Paulo, Brazil
A Study to Gain Information How Well Dexpanthenol Dermal Spray Helps the Skin to Recover After a Peeling in the External Genital Area of Women
Phase 4
Completed
- Conditions
- Skin Recovery
- Interventions
- Drug: BAY207543 (Bepanthol, Bepantol® Derma Spray)Other: Semisolid vaseline
- First Posted Date
- 2019-02-25
- Last Posted Date
- 2020-03-11
- Lead Sponsor
- Bayer
- Target Recruit Count
- 33
- Registration Number
- NCT03853512
- Locations
- 🇧🇷
Medcin Instituto da Pele, Sao Paulo, Brazil
A Study to Gain Information How Well Dexpanthenol Dermal Spray Helps the Face Skin to Recover After Cosmetic Lasering
Phase 4
Completed
- Conditions
- Skin RecoveryErythema
- Interventions
- Drug: BAY207543 (Bepanthol, Bepantol® Derma Spray)Other: Semisolid vaseline
- First Posted Date
- 2019-02-25
- Last Posted Date
- 2020-03-09
- Lead Sponsor
- Bayer
- Target Recruit Count
- 33
- Registration Number
- NCT03853538
- Locations
- 🇧🇷
Medcin Instituto da Pele, Sao Paulo, Brazil
Study to Learn More About the Benefits and Side-effects of Drugs Rivaroxaban and Apixaban Compared to the Drug Warfarin for Stroke Prevention in Patients With Rapid and Irregular Heartbeat Which is Not Due to a Heart-valve Fault (Non-valvular Atrial Fibrillation) in the UK Routine Clinical Practice
Completed
- Conditions
- Atrial Fibrillation
- Interventions
- First Posted Date
- 2019-02-20
- Last Posted Date
- 2021-10-28
- Lead Sponsor
- Bayer
- Target Recruit Count
- 45164
- Registration Number
- NCT03847181
- Locations
- 🇬🇧
Many facilities, Many Sites, United Kingdom
4 Week In-Use Study Evaluating How Well-Tolerated a Skin Care Product Is on Adults With Facial Redness
Not Applicable
Completed
- Conditions
- Rosacea
- Interventions
- Drug: Coppertone, BAY1183345
- First Posted Date
- 2019-02-15
- Last Posted Date
- 2019-06-12
- Lead Sponsor
- Bayer
- Target Recruit Count
- 35
- Registration Number
- NCT03841032
- Locations
- 🇺🇸
The Education & Research Foundation, Inc., Lynchburg, Virginia, United States
PROmyBETAappGame: a Study to Learn More About the Medication Usage & Patient Reported Outcomes Via the myBETAapp and to Find Out More About the Usage of Game Principles and Game Design Elements (Gamification) in Medical Care of Patients With Multiple Sclerosis Treated With Betaferon
Completed
- Conditions
- Multiple Sclerosis
- Interventions
- Other: myBETAappOther: PEAKDrug: Betaferon, BAY86-5046Device: BETACONNECT
- First Posted Date
- 2019-01-17
- Last Posted Date
- 2021-08-25
- Lead Sponsor
- Bayer
- Target Recruit Count
- 79
- Registration Number
- NCT03808142
- Locations
- 🇩🇪
Many locations, Multiple Locations, Germany
An Observational Study on Incidence, Natural History and Treatment Patterns of Venous Thromboembolism in Taiwan
Completed
- Conditions
- Venous Thromboembolism
- First Posted Date
- 2019-01-10
- Last Posted Date
- 2019-01-10
- Lead Sponsor
- Bayer
- Target Recruit Count
- 104215
- Registration Number
- NCT03799016
© Copyright 2025. All Rights Reserved by MedPath